Only one RCT that compared both interventions reported AEs among its predefined outcomes and showed a benign safety profile (42). The most frequently reported non-serious AE were gastrointestinal symptoms (diarrhea and nausea) observed in a small number of participants, without significant differences between the two interventions and the control group. No serious AEs were reported.